Nano X Imaging Ltd
$ 2.45
0.82%
25 Feb - close price
- Market Cap 160,188,000 USD
- Current Price $ 2.45
- High / Low $ 2.48 / 2.37
- Stock P/E N/A
- Book Value 2.40
- EPS -0.88
- Next Earning Report 2026-03-30
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.20 %
- ROE -0.35 %
- 52 Week High 6.42
- 52 Week Low 2.11
About
Nano-X Imaging Ltd., a development-stage company, develops, produces and markets digital X-ray source technology for the medical imaging industry globally. The company is headquartered in Neve Ilan, Israel.
Analyst Target Price
$7.40
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-20 | 2025-08-12 | 2025-05-26 | 2025-03-31 | 2024-11-26 | 2024-08-20 | 2024-05-28 | 2024-03-07 | 2023-11-28 | 2023-08-17 | 2023-05-22 | 2023-03-09 |
| Reported EPS | -0.15 | -0.23 | -0.2338 | -0.17 | -0.15 | -0.23 | -0.21 | -0.18 | -0.37 | -0.31 | -0.21 | -0.86 |
| Estimated EPS | -0.21 | -0.19 | -0.15 | -0.15 | -0.22 | -0.22 | -0.26 | -0.3 | -0.3 | -0.26 | -0.34 | -0.43 |
| Surprise | 0.06 | -0.04 | -0.0838 | -0.02 | 0.07 | -0.01 | 0.05 | 0.12 | -0.07 | -0.05 | 0.13 | -0.43 |
| Surprise Percentage | 28.5714% | -21.0526% | -55.8667% | -13.3333% | 31.8182% | -4.5455% | 19.2308% | 40% | -23.3333% | -19.2308% | 38.2353% | -100% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-30 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NNOX
2026-02-20 16:53:15
Nanox Imaging Ltd. has announced an exclusive distribution agreement with Intec SRL for its Nanox.ARC system in Argentina. This collaboration aims to expand access to cost-effective 3D medical imaging technology in Argentina's private healthcare sector. The Nanox.ARC system offers 3D imaging at a lower cost and reduced radiation compared to traditional CT scans.
2026-02-20 00:56:56
Nanox Imaging Ltd. has signed an exclusive distribution agreement with Intec SRL for its Nanox.ARC digital tomosynthesis system in Argentina. This partnership aims to expand access to cost-effective 3D medical imaging in Argentina's private healthcare sector. Intec SRL will handle marketing, distribution, installation, and support, contributing to Nanox's Latin American expansion strategy.
2026-02-19 20:56:39
Nanox Imaging Ltd. has announced an exclusive distribution agreement with Intec SRL for its Nanox.ARC system in Argentina. This partnership aims to expand access to cost-effective 3D medical imaging solutions in Argentina's private healthcare sector. Intec SRL will handle marketing, distribution, installation, and support, facilitating broader availability of the Nanox.ARC system, pending regulatory approvals.
2026-02-19 17:56:39
Nanox Imaging Ltd. has expanded its European presence through a new strategic alliance with Adriamed d.o.o. Beograd, a medical device distributor in Southeast Europe. This collaboration aims to enhance access to cost-effective medical imaging solutions, specifically bringing the Nanox.ARC digital tomosynthesis system to healthcare providers in Serbia, Montenegro, and Bosnia and Herzegovina. Adriamed will be the exclusive partner for distribution, installation, and support of the Nanox.ARC in the region, leveraging their local expertise to broaden market penetration.
2026-02-17 16:53:15
Nanox (Nasdaq: NNOX) announced it will showcase its Nanox.ARC digital tomosynthesis system live in Europe for the first time at the European Congress of Radiology (ECR) in Vienna from March 4-8, 2026. The company will also present new AI solutions, including FDA-cleared and CE-marked solutions for cardiac, bone, and liver analysis, as well as new data from the ADOPT study regarding AI-enabled vertebral fracture identification. This marks a significant step in Nanox's European market expansion, aiming to make advanced medical imaging more accessible and affordable.
2026-02-17 12:57:17
NANO-X IMAGING LTD (Nanox) will feature its Nanox.ARC digital tomosynthesis system for the first time in Europe at the European Congress of Radiology (ECR) from March 4-8, 2026, in Vienna. The company will conduct live demonstrations of the CE-marked and FDA-cleared Nanox.ARC, which offers cost-effective 3D imaging with reduced radiation, and present new clinical data on lung cancer screening. Nanox will also highlight its AI solutions for analyzing CT scans for chronic disease detection and introduce new AI solutions for aortic valve calcification and body composition measurement.
